BIOHLDG-PA logo

Bioalpha Holdings Berhad KLSE:BIOHLDG-PA Stock Report

Last Price

RM 0.005

Market Cap

RM 91.4m

7D

0%

1Y

-50.0%

Updated

23 Dec, 2024

Data

Company Financials

Bioalpha Holdings Berhad

KLSE:BIOHLDG-PA Stock Report

Market Cap: RM 91.4m

BIOHLDG-PA Stock Overview

An investment holding company, researches, develops, manufactures, imports, exports, trades in, and distributes nutritional and healthcare products in Malaysia, China, Indonesia, and internationally. More details

BIOHLDG-PA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Bioalpha Holdings Berhad Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bioalpha Holdings Berhad
Historical stock prices
Current Share PriceRM 0.005
52 Week HighRM 0.02
52 Week LowRM 0.005
Beta2.21
1 Month Change0%
3 Month Change-50.00%
1 Year Change-50.00%
3 Year Change-94.12%
5 Year Changen/a
Change since IPO-94.44%

Recent News & Updates

Recent updates

Shareholder Returns

BIOHLDG-PAMY Personal ProductsMY Market
7D0%-0.9%-0.7%
1Y-50.0%-13.4%10.2%

Return vs Industry: BIOHLDG-PA underperformed the MY Personal Products industry which returned -13.3% over the past year.

Return vs Market: BIOHLDG-PA underperformed the MY Market which returned 10% over the past year.

Price Volatility

Is BIOHLDG-PA's price volatile compared to industry and market?
BIOHLDG-PA volatility
BIOHLDG-PA Average Weekly Movementn/a
Personal Products Industry Average Movement3.6%
Market Average Movement4.8%
10% most volatile stocks in MY Market10.5%
10% least volatile stocks in MY Market2.5%

Stable Share Price: BIOHLDG-PA's share price has been volatile over the past 3 months compared to the MY market.

Volatility Over Time: Insufficient data to determine BIOHLDG-PA's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005n/aWilliam Honbioa.com.my

Bioalpha Holdings Berhad, an investment holding company, researches, develops, manufactures, imports, exports, trades in, and distributes nutritional and healthcare products in Malaysia, China, Indonesia, and internationally. It operates through Trading, Manufacturing, Retail Pharmacy, and Others segments. The company engages in the provision of advertising and promotion services for health supplements, nutrition products, personal care, functional food, and healthcare products; import, export, cultivation, manufacturing, distribution, and trading of various agro products and medical herbs; and planting, growing, and trading of herbs, fruits, agricultural, and agro and organic products.

Bioalpha Holdings Berhad Fundamentals Summary

How do Bioalpha Holdings Berhad's earnings and revenue compare to its market cap?
BIOHLDG-PA fundamental statistics
Market capRM 91.42m
Earnings (TTM)-RM 39.17m
Revenue (TTM)RM 82.49m

1.1x

P/S Ratio

-2.3x

P/E Ratio

Is BIOHLDG-PA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOHLDG-PA income statement (TTM)
RevenueRM 82.49m
Cost of RevenueRM 81.33m
Gross ProfitRM 1.16m
Other ExpensesRM 40.33m
Earnings-RM 39.17m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.028
Gross Margin1.41%
Net Profit Margin-47.49%
Debt/Equity Ratio2.2%

How did BIOHLDG-PA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 19:21
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bioalpha Holdings Berhad is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lee Fang NgCGS International
Michael KokalariMaybank Research Pte. Ltd.
Sze TeeMaybank Research Pte. Ltd.